Enzalutamide (Xtandi®) 40 mg capsules or 40 mg and 80 mg tablets clinical trials

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

This study is looking at a new medicine called ORIC-944 for men with advanced prostate cancer that has spread. It aims to find out if ORIC-944 is safe and if it helps shrink the cancer, both on its own and when given with other prostate cancer medicines.